News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rossi Christina
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,960 shares
@ $45.72, valued at
$135.3k
Sold 99 shares
@ $44.28, valued at
$4.4k
|
|
| 03/03/2023 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $43.15, valued at
$1.3M
|
|
| 11/07/2022 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 533 shares
@ $45.24, valued at
$24.1k
|
|
| 06/17/2022 |
4
| Rossi Christina (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 13,200 options to buy
@ $2.28, valued at
$30.1k
|
|
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2020 |
4
| Rossi Christina (Chief Commercial Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 345 shares
@ $99.69, valued at
$34.4k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Rossi Christina (Chief Commercial Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 6,500 options to buy
@ $86.6, valued at
$562.9k
Granted 1,750 restricted stock units
@ $0 |
|
| 11/05/2018 |
4
| Rossi Christina (Chief Commercial Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 80,000 options to buy
@ $65.75, valued at
$5.3M
Granted 4,500 restricted stock units
@ $0 |
|
|
|